Cargando…
SARS‐CoV‐2 re‐infection risk in Austria
BACKGROUND: A key question concerning coronavirus disease 2019 (COVID‐19) is how effective and long lasting immunity against this disease is in individuals who were previously infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). We aimed to evaluate the risk of SARS‐CoV‐2 re‐i...
Autores principales: | Pilz, Stefan, Chakeri, Ali, Ioannidis, John PA, Richter, Lukas, Theiler‐Schwetz, Verena, Trummer, Christian, Krause, Robert, Allerberger, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988582/ https://www.ncbi.nlm.nih.gov/pubmed/33583018 http://dx.doi.org/10.1111/eci.13520 |
Ejemplares similares
-
SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity
por: Pilz, Stefan, et al.
Publicado: (2022) -
Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials
por: Zittermann, Armin, et al.
Publicado: (2023) -
Mathematical Modeling of Free Thyroxine Concentrations During Methimazole Treatment for Graves’ Disease: Development and Validation of a Computer-Aided Thyroid Treatment Method
por: Theiler-Schwetz, Verena, et al.
Publicado: (2022) -
Automatic Levothyroxine Dosing Algorithm for Patients Suffering from Hashimoto’s Thyroiditis
por: Sharma, Ravi, et al.
Publicado: (2023) -
Vitamin D and Cardiovascular Disease: An Updated Narrative Review
por: Zittermann, Armin, et al.
Publicado: (2021)